Effects of manual acupuncture on fatty acid metabolism in a rat model of diarrhea-predominant irritable bowel syndrome: a multi-tissue metabolomic and plasma lipidomic investigation
Restricted accessResearch articleFirst published online August, 2025
Effects of manual acupuncture on fatty acid metabolism in a rat model of diarrhea-predominant irritable bowel syndrome: a multi-tissue metabolomic and plasma lipidomic investigation
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS. Many patients are dissatisfied with the efficacy of drug treatment and seek complementary and alternative medical therapies, especially acupuncture treatment. In this study, we evaluated the effect of manual acupuncture (MA) on IBS-D using a rat model and investigated the underlying mechanism of action by analyzing the changes in untargeted metabolomics of plasma/liver/colon and targeted plasma lipidomics.
Methods:
Thirty male Sprague–Dawley rats were divided into Control, IBS-D and MA groups (n = 10 each). IBS-D/MA groups received acetic acid enemas combined with restraint stress. The Control group received saline enemas. The MA group received daily MA at ST36 for 2 weeks after modeling. Pain and stool quality were measured by the abdominal withdrawal reflex (AWR) and Bristol stool form scale (BSFS). Plasma/liver/colon samples were collected for ultra-high performance liquid chromatography (UHPLC)/Q-Orbitrap mass spectromy (MS) untargeted metabolomics. Plasma was also subjected to UHPLC-MS/MS targeted lipidomics.
Results:
MA treatment improved BSFS and AWR scores in IBS-D model rats, suggesting reduced intestinal hypersensitivity. Metabolomic results showed that MA impacted 18 metabolites in the plasma, liver and colon, which were mainly involved in arachidonic acid metabolism, biosynthesis of unsaturated fatty acids, and amino sugar and nucleotide sugar metabolism. Targeted lipidomic results showed MA restored the low levels of four medium-chain and one long-chain fatty acids to normal levels in IBS-D, suggesting that acupuncture treatment of IBS-D involves fatty acid metabolic pathways.
Conclusion:
MA reduced markers of intestinal hypersensitivity and impacted a number of metabolic pathways in a rat model of IBS-D.
ZhaoYFGuoXJZhangZS, et al. Epidemiology of functional diarrhea and comparison with diarrhea-predominant irritable bowel syndrome: a population-based survey in China. PLoS ONE2012; 7(8): e43749.
2.
CamilleriMBuénoLAndresenV, et al. Pharmacologic, pharmacokinetic, and pharmacogenomic aspects of functional gastrointestinal disorders. Gastroenterology2016; 150: 1319–1331; e1320.
3.
DrossmanDA.Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology2016; 150: 1262–1279; e1262.
4.
BlackCJFordAC.Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol2020; 17(8): 473–486.
5.
SahaL.Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol2014; 20: 6759–6773.
6.
CamilleriM.Diagnosis and treatment of irritable bowel syndrome. JAMA2021; 325: 865–877.
7.
YanJMiaoZWLuJ, et al. Acupuncture plus Chinese herbal medicine for irritable bowel syndrome with diarrhea: a systematic review and meta-analysis. Evid Based Complement Alternat Med2019; 2019: 7680963.
8.
SunLYaoJLuoF, et al. The role of acupuncture on the autonomic nervous system in irritable bowel syndrome. Acupunct Herbal Med2023; 2: 063.
9.
Pacific WHOROftW. WHO standard acupuncture point locations in the Western Pacific Region. Geneva: World Health Organization, 2008.
10.
WangLAnJSongS, et al. Electroacupuncture preserves intestinal barrier integrity through modulating the gut microbiota in DSS-induced chronic colitis. Life Sci2020; 261: 118473.
11.
LiuGHLiuHMChenYS, et al. Effect of Electroacupuncture in Mice with Dextran Sulfate Sodium-Induced Colitis and the Influence of Gut Microbiota. Evid Based Complement Alternat Med2020; 2020: 2087903.
12.
WangLHeC.Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. Front Immunol2022; 13: 967193.
13.
SongSAnJLiY, et al. Electroacupuncture at ST-36 ameliorates DSS-induced acute colitis via regulating macrophage polarization induced by suppressing NLRP3/IL-1β and promoting Nrf2/HO-1. Mol Immunol2019; 106: 143–152.
14.
ChenTZhangWWChuYX, et al. Acupuncture for pain management: molecular mechanisms of action. Am J Chin Med2020; 48(4): 793–811.
15.
WangXYLiCYZhangYN, et al. [Effect of electroacupuncture on 5-HT7R in gastric antrum and colon tissues of functional diarrhea rats]. Zhen Ci Yan Jiu2021; 46: 549–554.
16.
QinYGuoMWLanY, et al. [Effect of electroacupuncture of “Hegu” (LI4) and “Zusanli” (ST36) on intestinal sensitivity and motility in irritable bowel syndrome rats]. Zhen Ci Yan Jiu2020; 45: 293–298.
17.
ChenQZhangHSunCY, et al. Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome. Mol Med2023; 29: 5.
18.
ZhuangZMWangXTZhangL, et al. The effect of PDIA3 gene knockout on the mucosal immune function in IBS rats. Int J Clin Exp Med2015; 8(5): 6866–6877.
19.
CareNRCU. The National Academies Collection: Reports funded by National Institutes of Health. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academies Press, 2011.
20.
BourduSDapoignyMChapuyE, et al. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology2005; 128(7): 1996–2008.
21.
ZhuangZHuangCZhangY, et al. Effects of massa medicata fermentata on the intestinal pathogenic flagella bacteria and visceral hypersensitivity in rats with irritable bowel syndrome. Front Physiol2022; 13: 1039804.
22.
WangSJYangHYXuGS.Acupuncture alleviates colorectal hypersensitivity and correlates with the regulatory mechanism of TrpV1 and p-ERK. Evid Based Complement Alternat Med2012; 2012: 483123.
23.
Al-ChaerEDKawasakiMPasrichaPJ.A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology2000; 119(5): 1276–1285.
24.
LewisSJ.Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol1997; 32(9): 920–924.
25.
WangLHuangSZhuT, et al. Metabolomic Study on Iohexol-Induced Nephrotoxicity in Rats Based on NMR and LC-MS Analyses. Chem Res Toxicol2022; 35: 244–253.
26.
TanYWangLGaoJ, et al. Multiomics Integrative Analysis for Discovering the Potential Mechanism of Dioscin against Hyperuricemia Mice. J Proteome Res2021; 20: 645–660.
27.
ChengLWangLChenB, et al. A multiple-metabolites model to predict preliminary renal injury induced by iodixanol based on UHPLC/Q-Orbitrap-MS and (1)H-NMR. Metabolomics2022; 18: 85.
28.
HaoLWangJPageD, et al. Comparative evaluation of MS-based metabolomics software and its application to preclinical Alzheimer’s disease. Sci Rep2018; 8: 9291.
29.
PengALinLZhaoM, et al. Identifying mechanisms underlying the amelioration effect of Chrysanthemum morifolium Ramat. “Boju” extract on hyperuricemia using biochemical characterization and UPLC-ESI-QTOF/MS-based metabolomics. Food Funct2019; 10: 8042–8055.
30.
DingLZhangCLiuZ, et al. Metabonomic investigation of biological effects of a new vessel target protein tTF-pHLIP in a mouse model. J Proteome Res2020; 19: 238–247.
31.
HotellingH.The generalization of Student’s ratio. In: KotzSJohnsonNL (eds) Breakthroughs in Statistics: Foundations and Basic Theory. London: Springer, 1992, pp. 54–65.
32.
XianMShenLZhanS, et al. Integrated 16S rRNA gene sequencing and LC/MS-based metabolomics ascertained synergistic influences of the combination of acupuncture and NaoMaiTong on ischemic stroke. J Ethnopharmacol2022; 293: 115281.
33.
SarafianMHGaudinMLewisMR, et al. Objective set of criteria for optimization of sample preparation procedures for ultra-high throughput untargeted blood plasma lipid profiling by ultra performance liquid chromatography-mass spectrometry. Anal Chem2014; 86: 5766–5774.
34.
SelmiHWalkerADebarbieuxL, et al. Improving the intestinal lipidome coverage in a gnotobiotic mouse model using UHPLC-MS-based approach through optimization of mobile phase modifiers and column selection. J Chromatogr B Analyt Technol Biomed Life Sci2024; 1242: 124188.
35.
WangQSongWTianY, et al. Targeted lipidomics reveal the effect of perchlorate on lipid profiles in liver of high-fat diet mice. Front Nutr2022; 9: 837601.
36.
WuJCChanAOChanYW, et al. The current treatment landscape of irritable bowel syndrome in adults in Hong Kong: consensus statements. Hong Kong Med J2017; 23(6): 641–647.
37.
WangYChenNNiuF, et al. Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs. Int J Colorectal Dis2022; 37(11): 2263–2276.
38.
IharaEManabeNOhkuboH, et al. Evidence-based clinical guidelines for chronic diarrhea 2023. Digestion2024; 105(6): 480–497.
39.
ZhangAYanGSunH, et al. Deciphering the biological effects of acupuncture treatment modulating multiple metabolism pathways. Sci Rep2016; 6: 19942.
40.
SalaAProschakESteinhilberD, et al. Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade. Biochem Pharmacol2018; 158: 161–173.
41.
TallimaHEl RidiR.Arachidonic acid: Physiological roles and potential health benefits—a review. J Adv Res2018; 11: 33–41.
42.
CapdevilaJMarnettLJChacosNProughRAEstabrookRW.Cytochrome P-450-dependent oxygenation of arachidonic acid to hydroxyicosatetraenoic acids. Proc Natl Acad Sci USA1987; 79: 4.
43.
CampbellWBGebremedhinDPrattPF, et al. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res1996; 78(3): 415–423.
ImigJDNavarLGRomanRJ, et al. Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol1996; 7(11): 2364–2370.
46.
SacerdotiDGattaAMcGiffJC.Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology. Prostaglandins Lipid Mediat2003; 72(1-2): 51–71.
47.
NodeKHuoYRuanX, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science1999; 285: 1276–1279.
48.
KozakWAronoffDMBoutaudO, et al. 11, 12-epoxyeicosatrienoic acid attenuates synthesis of prostaglandin E2 in rat monocytes stimulated with lipopolysaccharide. Exp Biol Med2003; 228(7): 786–794.
GoesACPintoFMFernandesGC, et al. Electroacupuncture ameliorates experimental colitis induced by TNBS through activation of interleukin-10 and inhibition of iNOS in mice. Acta Cir Bras2014; 29(12): 787–793.
52.
BladCCTangCOffermannsS.G protein-coupled receptors for energy metabolites as new therapeutic targets. Nat Rev Drug Discov2012; 11(8): 603–619.
53.
HaraTKimuraIInoueD, et al. Free fatty acid receptors and their role in regulation of energy metabolism. Rev Physiol Biochem Pharmacol2013; 164: 77–116.
54.
RegardJBSatoITCoughlinSR.Anatomical profiling of G protein-coupled receptor expression. Cell2008; 135: 561–571.
55.
ItohYKawamataYHaradaM, et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature2003; 422: 173–176.
56.
NagasumiKEsakiRIwachidowK, et al. Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice. Diabetes2009; 58(5): 1067–1076.
57.
MaslowskiKMVieiraATNgA, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature2009; 461: 1282–1286.
58.
SalagaMBartoszekABiniendaA, et al. Activation of free fatty acid receptor 4 affects intestinal inflammation and improves colon permeability in mice. Nutrients2021; 13: 2716.
59.
OhDYTalukdarSBaeEJ, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell2010; 142: 687–698.
60.
ZhangLSZhangZSWuYZ, et al. Activation of free fatty acid receptors, FFAR1 and FFAR4, ameliorates ulcerative colitis by promote fatty acid metabolism and mediate macrophage polarization. Int Immunopharmacol2024; 130: 111778.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
